Navigation Links
Indiana's $44 Billion Life Sciences Industry Packs a Powerful Punch

INDIANAPOLIS, June 23, 2011 /PRNewswire/ -- A rapidly growing life sciences industry has a $44 billion total impact on Indiana's economy, according to a comprehensive new report released today by BioCrossroads.  The report, Indiana's Life Sciences Industry: 2002-2010—Tracking Progress and Charting the Course for Continued Success, authored by Walter H. Plosila, Ph.D., and based on data gathered by the Indiana Business Resource Center at the Indiana University Kelley School of Business, illustrates a decade of substantial growth and measurable progress across a wide range of nationally significant indicators.

For example, the report notes that by 2009, Indiana's life sciences exports totaled $7.4 billion, ranking the third highest in the United States, behind only California and Texas.  The state has the third highest life sciences employment concentration* nationally, and has seen a 21% increase in life sciences employment, adding more than 8,800 new jobs to the industry since 2002. More than 50,000 workers at 825 companies comprise four life sciences sub-sectors: medical devices and equipment, drugs and pharmaceuticals, research, testing and medical laboratories, and agricultural feedstock and chemicals.  Indiana's health information technology sector contributes an additional 2,500 workers and 72 companies.

The report also highlights the progress of Indiana's life sciences companies in discovering and commercializing thousands of new products over the past decade.  There were 2,226 U.S. Food and Drug Administration filings between 2005 and 2010 – the Hoosier state had the ninth highest number of 510(k) applications with 1,821 and the 11th highest number of Premarket Approval applications with 405.

"There are three key components to having a thriving innovation cluster:  the sector must be based on real assets, must draw substantial corporate and philanthropic investment, and must be sustained by the investments of others who care about it," said David Johnson, president and CEO of BioCrossroads.  "This new report demonstrates that Indiana has all of those elements working together.  Compared to other states and regions, we have a significant competitive advantage because of our focus on cultivating a skilled workforce, engaged university and academic institutions, strong philanthropic support, novel public-private partnerships, access to capital and a positive business climate."

Other key findings in the report:

  • More than $600 million in philanthropic funding has bolstered the life sciences community since 2000.
  • Over 1,900 life sciences-related patents have been issued to Indiana holders since 2004.
  • From 2005 to 2010, Indiana opportunities received nearly $1.8 billion in capital investment for new and existing life sciences companies.

"Indiana's life sciences sector is one of the nation's success stories, and BioCrossroads has been catalytic in its sustained and strategic efforts to make the state a leader in this growing global industry," said Plosila, who also authored the Battelle's original report on the potential of Indiana's life sciences sector in 2002, where he served as vice president, Technology Partnership Practice, prior to retiring in 2008.  "I have followed the state's progress over the last eight years.  Through the partnerships BioCrossroads and its members have built and their focus on existing strengths and emerging opportunities, Indiana offers a model for other cluster initiatives to follow.  The state is well positioned to continue this growth and leadership."

Indiana is home to the global headquarters for: Biomet, Cook Medical, DePuy Orthopaedics, Dow AgroSciences, Eli Lilly and Company, WellPoint, and Zimmer and the North American headquarters of Roche Diagnostics; Beckman Coulter, Boston Scientific, Covance, Mead Johnson and Medco have major operations located within the state. 

The full report and a quick facts sheet are available at  

About BioCrossroads

BioCrossroads ( is Indiana's initiative to grow, advance and invest in the life sciences, a publicprivate collaboration that supports the region's existing research and corporate strengths while encouraging new business development.  BioCrossroads provides money and support to life sciences businesses, launches new life sciences enterprises (Indiana Health Information Exchange, Fairbanks Institute for Healthy Communities, BioCrossroadsLINX, OrthoWorx and Datalys Center), expands collaboration and partnerships among Indiana's life science institutions, promotes science education and markets Indiana's life sciences industry.

*Employment concentration is a useful way to gauge a state or county's degree of specialization in a given industry or cluster of industries.  Location Quotients (LQs) measure the degree of job concentration within the region relative to the nation.  A county LQ greater than 1.0 is said to have a greater concentration than the national average.  When the LQ is significantly above average, 1.20 or greater, the county is said to have a "specialization" in the industry.  (Battelle)

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

David Johnson

SOURCE BioCrossroads
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Parenteral Depots Offer $8 Billion of Reformulation Opportunities and a Strong Competitive Edge in Crowded Pharmaceutical Space
2. DuPont to Acquire Danisco for $6.3 Billion
3. Martek Is Second Mtech Company Sold for More Than $1 Billion in Three Years
4. Stryker Announces Definitive Agreement to Acquire the Neurovascular Division of Boston Scientific for $1.5 Billion
5. Combined Sales of Seven Emerging Therapies for Breast Cancer, Including Drugs From Sanofi-Aventis and AstraZeneca, Will Total Nearly $5 Billion by 2019
6. HumanTouch Expands Services to the Centers for Disease Control and Prevention as a Prime Contract Holder as Part of $1.0 Billion Contract
7. Due to Generic Erosion, the Hypertension Drug Market Will Decline by $3 Billion from 2009 to 2019
8. Immune Biosimilars Will Erode $10.8 Billion in Immune Biologics Brand Sales in 2019 Across the U.S., EU5 and Japan
9. Regenerative Medicine Market Expected to Reach $4.5 Billion by 2014
10. MarketsandMarkets: Global Bioinformatics Market Worth $8.3 billion by 2014
11. Details Issued Today on $1 Billion in Biotech Tax Credits and Grants
Post Your Comments:
(Date:10/13/2015)... , ... October 13, 2015 , ... ... recombinant antibodies, today announced that it has received a Phase I Small Business ... by the National Institute of General Medical Sciences (NIGMS), will fund the development ...
(Date:10/13/2015)... , October 13, 2015 ... and development company, has entered into a strategic relationship ... and Paris, France ... --> --> This collaborative arrangement gives ... respected scientific advisory team as well as long established ...
(Date:10/13/2015)... , Oct. 13, 2015  According to Kalorama ... will reach $102 billion by the end of ... the health industry, as it is estimated that ... of laboratory tests. In addition to diagnosing patients, ... evaluate disease progression, monitor drug treatment and conditions, ...
(Date:10/13/2015)... ... October 13, 2015 , ... ... of automation systems, material handling solutions and components, is opening its latest Parker ... State Street, the facility is Exotic’s second major expansion in Metropolitan Detroit in ...
Breaking Biology Technology:
(Date:10/8/2015)... Oktober 2015 Die Track Group, ... des Bereiches Tracking, hat heute bekannt gegeben, ... Virginias (Department of Corrections – DOC) unterzeichnet ... alle Strafen geliefert werden, die der Behörde ... für den Amerikanischen Kontinent der Track Group. ...
(Date:10/6/2015)... 2015 Track Group, Inc. (OTCQX: TRCK), a ... signed a contract with the Virginia Department of Corrections ... of sentences under the Department,s oversight. Derek ... contract with the Virginia DOC will expand our footprint ... our position as a trusted leader in offender electronic ...
(Date:10/1/2015)... Oct. 1, 2015  Biometrics includes diverse set ... body characteristics, such as fingerprints, eye retinas, facial ... of biometrics technology has been constantly increasing in ... five years. In addition to the most prominent ... recognition, other means of biometric authentication are rapidly ...
Breaking Biology News(10 mins):